Publications by fellows based on scholarly work done at Yale during their fellowship (2010-present):
Ryder AB, Hendrickson JE, Tormey CA. Chronic inflammatory autoimmune disorders are a risk factor for
red blood cell alloimmunization. Br J Haematol [Epub ahead of print]
Hendrickson JE, Hendrickson ET, Gehrie EA, Sidhu D, Wallukat G, Schimke I, Tormey CA. Complex
regional pain syndrome and dysautonomia in a 14-year-old girl responsive to therapeutic plasma
exchange. J Clin Apher [Epub ahead of print]
Unold D, Tormey CA. Clinical applications of 4-factor prothrombin complex concentrate: A practical
pathologist's perspective. Arch Pathol Lab Med 2015;139:1568-75.
Gehrie EA, Hendrickson JE, Tormey CA. Measuring the influence of blood component infusion rate on
recipient vital signs. Vox Sang 2015;109:353-8.
Gehrie EA, Hendrickson JE, Tormey CA. Variation in vital signs resulting from blood component
administration in adults. Transfusion 2015;55:1866-71.
Gehrie E, Tormey C. Novel oral anticoagulants: efficacy, laboratory measurement, and approaches to
emergent reversal. Arch Pathol Lab Med 2015;139:687-92.
Unni N, Peddinghaus M, Tormey CA, Stack G. Record fragmentation due to transfusion at multiple health
care facilities: a risk factor for delayed hemolytic transfusion reactions. Transfusion 2014;54:98-103.
Gehrie EA, Tormey CA. The influence of clinical and biological factors on transfusion-associated non-ABO
antigen alloimmunization: Responders, hyper-responders, and non-responders. Transfus Med Hemother
2014;41:420-9.
Gehrie EA, Tormey CA. The development and implementation of, and first years' experience with, a
massive/emergency transfusion protocol (damage control hematology protocol) in a Veterans Affairs
hospital. Mil Med 2014;179:1099-105.
Ryder AB, Zimring JC, Hendrickson JE. Factors influencing RBC alloimmunization: Lessons learned from
murine models. Transfus Med Hemother 2014;41:406-19.
Maitta RW, Avery L, Champion M, Vaughn D, Baillargeon C, Lederer J, Snyder EL. How do we integrate
transfusion medicine and tissue dispensing programs in an academic medical center: response to a
changing regulatory environment. Transfusion 2012;52:1172-81.
Maitta RW, Choate J, Emre SH, Luczycki SM, Wu Y. Emergency ABO-incompatible liver transplant
secondary to fulminant hepatic failure: outcome, role of TPE and review of the literature. J Clin Apher.
2012;27:320-9.
Choate J, Snyder EL. The rise of cellular therapy. Transfus Apher Sci 2011;45:91-7.
Snyder E, Choate J. The emergence of cellular therapy: impact on transfusion medicine. Transfusion
2010;50:2301-9.
Tormey CA, Peddinghaus ME, Erickson M, King KE, Cushing MM, Bill J, Goodrich T, Snyder EL. Improved
plasma removal efficiency for therapeutic plasma exchange using a new apheresis platform. Transfusion
2010;50:471-7.